Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.

Slides:



Advertisements
Similar presentations
Batuhan Ozmen, Murat Sönmezer, Cem Somer Atabekoglu, Hülya Olmuş 
Advertisements

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis  Sesh Kamal Sunkara, Jyotsna Pundir,
Programmes and prospects for ovotechnology
Modified natural cycle IVF and mild IVF: a 10 year Swedish experience
Attitudes and policies regarding access to fertility care and assisted reproductive technologies in Israel  Daniel Sperling, Yael Simon  Reproductive.
Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C
Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: randomized controlled trial  Eman A. Elgindy, Ahmed.
Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase  TG Lainas, IA Sfontouris, IZ Zorzovilis, GK Petsas,
Hatem Abu Hashim  Reproductive BioMedicine Online 
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
Double GnRH-antagonist dose before HCG administration may prevent OHSS in oocyte-donor cycles: a pilot study  Yannis Prapas, Ioannis Panagiotidis, Ioannis.
Bruce S. Shapiro, Said T. Daneshmand, Humberto Restrepo, Forest C
Higher β-HCG concentrations and higher birthweights ensue from single vitrified embryo transfers  Kevin N. Keane, Kamarul Bahyah Mustafa, Peter Hinchliffe,
A. Osman, J. Pundir, M. Elsherbini, S. Dave, T. El-Toukhy, Y. Khalaf 
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF  Bart C.J.M. Fauser, Michael.
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial  Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens,
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 
Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation  Hermann M. Behre, Colin.
Jacob Farhi, Onit Sapir, Maor Maman, Benjamin Fisch, Avi Ben-Haroush 
Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol)  Yanping Kuang, Qiuju Chen,
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation  Giovanna Sighinolfi,
Female gender pre-selection by maternal diet in combination with timing of sexual intercourse – a prospective study  A.M. Noorlander, J.P.M. Geraedts,
Establishment and validation of a score to predict ovarian response to stimulation in IVF  Clelia Chalumeau, Jessika Moreau, Nicolas Gatimel, Clementine.
Why are reproductive cancers more common in nulliparous women?
Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis  Mohan Shashikant Kamath, Richard Kirubakaran, Mariano.
Maternal concentrations of human chorionic gonadotrophin in very early IVF pregnancies and duration of pregnancy: a follow-up study  Tom G. Tanbo, Manuela.
Novel aspects of the endocrinology of the menstrual cycle
Sarah McCredie, William Ledger, Christos A. Venetis 
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber 
Association of skewed X chromosome inactivation and idiopathic recurrent spontaneous abortion: a systematic review and meta-analysis  Yilun Sui, Qianqian.
Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa  F. Olivennes, G. Trew,
Cross-border reproductive care: a review of the literature
Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial  Vivian Chi Yan Lee, Carina Chi Wai Chan,
Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf 
Spontaneous ovulation versus HCG triggering for timing natural-cycle frozen–thawed embryo transfer: a randomized study  Ariel Weissman, Eran Horowitz,
Batuhan Ozmen, Murat Sönmezer, Cem Somer Atabekoglu, Hülya Olmuş 
A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor  X.J. Sun, L. Jiang, L.C. Ji, R. Nie,
Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors  Alberta Maria Fabris, Maria Cruz, Carlos Iglesias,
Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial  Juan Antonio García-Velasco, Sanja.
A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment  S.E. Elizur, W.Y. Son, H. Clarke, D. Morris,
V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss 
Michael J. Levy, William Ledger, Efstratios M. Kolibianakis, Pieta C
Double GnRH-antagonist dose before HCG administration may prevent OHSS in oocyte-donor cycles: a pilot study  Yannis Prapas, Ioannis Panagiotidis, Ioannis.
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles  Kevin Doody, Paul Devroey, Keith Gordon, Han Witjes, Bernadette Mannaerts 
Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: a meta-analysis  IP Kosmas, K Zikopoulos, I Georgiou, E Paraskevaidis, C.
Should we be promoting embryo transfer at blastocyst stage?
Is the time interval between HCG administration and oocyte retrieval associated with oocyte retrieval rate?  Julia K. Bosdou, Efstratios M. Kolibianakis,
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
Anna Pia Ferraretti, Paul Devroey, M. Cristina Magli, Luca Gianaroli 
GnRH antagonist pre-treatment: one centre's experience for IVF–ICSI cycle scheduling  Veronique Viardot-Foucault, Sadhana Nadarajah, Weng Kit Lye, Heng.
Ovarian stimulation and endometriosis progression or recurrence: a systematic review  Edgardo Somigliana, Paola Viganò, Laura Benaglia, Andrea Busnelli,
Pietro Gambadauro, Ramesan Navaratnarajah 
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature  Micah J. Hill, Gary Levy, Eric D. Levens 
The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting    Reproductive BioMedicine Online 
Response: time-lapse systems for ART
Cryopreserved embryo transfer: adjacent or non-adjacent to failed fresh long GnRH- agonist protocol IVF cycle  Alexander Volodarsky-Perel, Talia Eldar-Geva,
A. La Marca, S. M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, L
Progesterone elevation on the day of HCG administration may affect rescue ICSI  Bo Huang, Zhou Li, Lixia Zhu, Dan Hu, Qun Liu, Guijin Zhu, Hanwang Zhang 
Nigel Pereira, Anna Voskuilen-Gonzalez, Kolbe Hancock, Jovana P
Ovarian reserve screening before contraception?
Programmes and prospects for ovotechnology
Randomized controlled trial of benzocaine versus placebo spray for pain relief at hysterosalpingogram  E.A. Bachman, S. Senapati, M.D. Sammel, S.K. Kalra 
Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study  Georg Griesinger, Henriette.
Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation 
M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein 
High oestradiol concentration after ovarian stimulation is associated with lower maternal serum beta-HCG concentration and neonatal birth weight  Suying.
Presentation transcript:

Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive BioMedicine Online  Volume 39, Issue 2, Pages 321-331 (August 2019) DOI: 10.1016/j.rbmo.2019.03.212 Copyright © 2019 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Organization of a conventional ovarian stimulation (OS) protocol with gonadotrophin-releasing hormone (GnRH) antagonist versus a progestin-primed ovarian stimulation (PPOS) protocol. HCG, human chorionic gonadotrophin. Reproductive BioMedicine Online 2019 39, 321-331DOI: (10.1016/j.rbmo.2019.03.212) Copyright © 2019 Reproductive Healthcare Ltd. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.